-
公开(公告)号:US6048899A
公开(公告)日:2000-04-11
申请号:US107206
申请日:1998-06-29
申请人: Harold Kohn , Shridhar V. Andurkar
发明人: Harold Kohn , Shridhar V. Andurkar
IPC分类号: C07C237/06 , C07C237/52 , A61K31/16 , A61K31/165 , C07C233/05 , C07C235/06
CPC分类号: C07C237/52 , C07C237/06
摘要: The present invention is directed to N-benzyl-2-amino-3-methoxypropionamide and stereoisomers the use thereof anti-convulsant and an intermediate in the preparation of other anti-convulsants.
摘要翻译: 本发明涉及N-苄基-2-氨基-3-甲氧基丙酰胺及其立体异构体,其用于抗惊厥药和制备其它抗惊厥药的中间体。
-
公开(公告)号:US5767103A
公开(公告)日:1998-06-16
申请号:US244179
申请日:1995-04-19
IPC分类号: A61K31/70
CPC分类号: A61K31/714
摘要: The present invention describes a method of sequestering nitric oxide from the bloodstream, endothelium or tissues of mammals by administering a cobalamin to such mammals. A method of treating diseases characterized by elevated nitric oxide levels in the bloodstream, endothelium or tissues is further provided. In particular, a method of treating sepsis by administering a therapeutic dose of hydroxocobalamin is described by the present invention. A method of alleviating systemic hypotension in a septic patient is further described by this invention. A pharmaceutical composition comprising a cobalamin in a concentration ranging from 0.5 to 50 mg composition/Kg body weight for mammals and is also provided.
摘要翻译: PCT No.PCT / US94 / 05650 Sec。 371日期1995年04月19日 102(e)1995年4月19日PCT PCT 1994年5月17日PCT公布。 公开号WO95 / 31204 日期1995年11月23日本发明描述了通过向这些哺乳动物施用钴胺素来从哺乳动物的血液,内皮或组织中螯合一氧化氮的方法。 还提供了治疗以血流,内皮或组织中一氧化氮水平升高为特征的疾病的方法。 特别地,本发明描述了通过施用治疗剂量的羟钴胺素治疗败血症的方法。 通过本发明进一步描述了减轻脓毒症患者的全身性低血压的方法。 还提供了包含对哺乳动物浓度为0.5至50mg组合物/ Kg体重的钴胺素的药物组合物。
-
公开(公告)号:US5698675A
公开(公告)日:1997-12-16
申请号:US468593
申请日:1995-06-06
申请人: Louis A. Carpino
发明人: Louis A. Carpino
IPC分类号: C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04 , C07F9/6561 , C07K1/08 , C07K1/10 , C07D403/00
CPC分类号: C07F9/6561 , C07D471/04 , C07D491/04 , C07D495/04 , C07D513/04 , C07K1/082 , C07K1/084 , C07K1/10
摘要: This invention relates to a process for forming an amide or an ester from a reaction between an amine or an alcohol, respectively and an acylating derivative of a carboxylic acid, in the presence of an effective amount of a compound having the formula: ##STR1## and N-oxides thereof and salts thereof.
摘要翻译: 本发明涉及在有效量的具有下式的化合物的存在下,分别由胺或醇与羧酸的酰化衍生物之间的反应形成酰胺或酯的方法:< IMAGE> 及其N-氧化物及其盐。
-
公开(公告)号:US5562925A
公开(公告)日:1996-10-08
申请号:US252668
申请日:1994-06-02
CPC分类号: A61K33/24
摘要: Malignant tumors in animals are treated by parenterally administering to an affected animal a solution containing a complex compound of platinum in an amount effective to cause regression of the tumor.
摘要翻译: 动物中的恶性肿瘤通过肠胃外给予受影响的动物来治疗,该溶液含有有效引起肿瘤消退的量的铂复合化合物。
-
公开(公告)号:US5157020A
公开(公告)日:1992-10-20
申请号:US528210
申请日:1990-05-24
IPC分类号: A61K8/72 , A61K8/00 , A61K8/64 , A61K38/00 , A61K39/00 , A61K39/395 , A61P43/00 , A61Q19/00 , A61Q19/08 , C07K1/14 , C07K7/08 , C07K14/705 , C07K16/00 , G01N33/53 , G01N33/564
CPC分类号: C07K14/705 , A61K38/00
摘要: Disclosed herein is a synthetic senescent cell antigen comprised of purified peptides immunoreactive with antibodies to the naturally occurring antigen. Preferably, the synthetic senescent cell antigen comprises two peptides with the amino acid sequences SKLIKIFQDHPLQKTYN and LFKPPKYHPDVPYVKR, respectively. The antigen and peptides may be used in compositions, diagnostic kits, and methods for detecting or measuring antibodies to senescent cell antigen, studying cellular aging and autoimmune mechanisms, separating anions from a gas or liquid, or treating certain diseases.
摘要翻译: 本文公开了合成的衰老细胞抗原,其由与天然存在抗原的抗体免疫反应的纯化肽组成。 优选地,合成的衰老细胞抗原包含分别具有氨基酸序列SKLIKIFQDHPLQKTYN和LFKPPKYHPDVPYVKR的两个肽。 抗原和肽可以用于组合物,诊断试剂盒和用于检测或测量抗衰老细胞抗原的抗体,研究细胞衰老和自身免疫机制,从气体或液体中分离阴离子或治疗某些疾病的方法。
-
公开(公告)号:US5880158A
公开(公告)日:1999-03-09
申请号:US938527
申请日:1997-09-26
申请人: Harold Kohn
发明人: Harold Kohn
IPC分类号: C07C235/06 , C07C235/34 , A61K31/16 , C07C233/05
CPC分类号: C07C235/34 , C07C235/06 , C07B2200/07
摘要: The present invention is directed to a compound of the following formula: ##STR1## pharmaceutical compositions containing the same and the use thereof as an anticonvulsant.
摘要翻译: 本发明涉及下式的化合物:含有它们的药物组合物及其作为抗惊厥药的用途。
-
公开(公告)号:US5656621A
公开(公告)日:1997-08-12
申请号:US196606
申请日:1994-02-15
IPC分类号: C07J1/00 , C07J11/00 , C07J13/00 , C07J17/00 , C07J21/00 , C07J41/00 , C07J51/00 , C07J53/00 , C07J71/00 , A61K31/565
CPC分类号: C07J17/00 , C07J1/0011 , C07J1/0022 , C07J1/0025 , C07J11/00 , C07J13/005 , C07J21/003 , C07J21/008 , C07J41/0005 , C07J41/0016 , C07J41/005 , C07J51/00 , C07J53/00 , C07J53/004 , C07J71/001
摘要: ##STR1## useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agent.
摘要翻译:
可用作抗癌,抗肥胖,抗高血糖,抗自身免疫和抗高胆固醇血症药。 -
公开(公告)号:US6162925A
公开(公告)日:2000-12-19
申请号:US442648
申请日:1999-11-18
申请人: Robert M. Williams , Chenguang Yuan
发明人: Robert M. Williams , Chenguang Yuan
IPC分类号: C07D239/22 , C07C275/70
CPC分类号: C07D239/22
摘要: The present invention is directed to anti-bacterial and anti-tumor agents and the synthesis thereof.
摘要翻译: 本发明涉及抗细菌和抗肿瘤剂及其合成。
-
公开(公告)号:US6057116A
公开(公告)日:2000-05-02
申请号:US869285
申请日:1997-06-02
申请人: Juergen R. Vielkind
发明人: Juergen R. Vielkind
CPC分类号: C07K14/4748 , C07K16/3053 , C07K16/3069 , C07K16/40 , G01N33/5743 , G01N33/57434 , G01N33/57492 , A61K38/00 , C07K2317/34 , G01N2333/705 , G01N2333/91215
摘要: Methods and compositions are provided for detecting antigens having a specific epitope associated with melanoma and prostatic carcinoma. The epitope is present in melanoma cells and prostatic cancer cells but is essentially absent from melanocytes and normal prostatic tissue. The antibody can be used in diagnostic methods for histochemical detection of human melanoma and prostate carcinoma, of various progression stages and in treatment of melanoma and prostate carcinoma.
-
公开(公告)号:US5616605A
公开(公告)日:1997-04-01
申请号:US287320
申请日:1994-08-08
IPC分类号: A61K38/00 , C07C259/06 , C07C317/44 , C07C323/60 , C07K5/065 , C07K5/078 , C07D209/12 , A61K31/405 , C07D209/14
CPC分类号: C07C259/06 , C07C317/44 , C07C323/60 , C07K5/06078 , C07K5/06139 , A61K38/00
摘要: This invention is directed to a collagenase inhibitor of the formula: ##STR1##
摘要翻译: 本发明涉及下式的胶原酶抑制剂:
-
-
-
-
-
-
-
-
-